Cipher Pharmaceuticals Inc. (TSX:CPH)
Canada · Delayed Price · Currency is CAD 14.67
-0.19 (-1.28%)
Sep 18, 2026, 4:00 PM EST
Cipher Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Cipher Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $19.95. The average 1-year stock price forecast is 35.99% higher than the current stock price, while the lowest is $17.00 (+15.88%) and the highest is $22.00 (+49.97%).
Price Target: $19.95 (+35.99%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Aug 13, 2026.
Analyst Ratings
The average analyst rating for Cipher Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $22.00 → $20.00 | Buy | Maintains | $22.00 → $20.00 | +36.33% | Aug 13, 2026 |
Financial Forecast
Revenue This Year
52.01M
from 50.45M
Increased by 3.09%
Revenue Next Year
59.72M
from 52.01M
Increased by 14.82%
EPS This Year
n/a
EPS Next Year
n/a